Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of barusiban on implantation and pregnancy rates in IVF/ICSI patients
2012-001622-10Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in female infertility comparing barusiban with placebo (2 arms). Primary endpoint: ongoing implantation rate. Started Oct 2012; status: completed.
02
Drugs
barusiban
03
Conditions
female infertility
Beyond the preview
Go deeper on 2012-001622-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001622-10.